Variant
FLT3 ITD N676K
CI-VAR-00002050Explore in graph →CIViC 2785
Curated evidence
Evidence by cancer (2 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 26438511
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Acute Myeloid Leukemia2 | ||||||||
| FLT3 ITD N676K | (oncogenic) | Oncogenic | C | Supports Oncogenicity | 3 | submitted | EID9144Acute myeloid leukemia (AML) with an FLT3 internal tandem duplication (FLT3-ITD) mutation is an aggressive hematologic malignancy with a grave prognosis. Targeted deep sequencing was performed on FLT3… (full text at CIViC) PMID 26438511 · Garg et al., 2015 · Open in CIViC | civic |
| FLT3 ITD N676K | Midostaurin | Predictive | C | Supports Resistance | 3 | submitted | EID7524In a study looking for mechanisms of resistance within a phase 2 study using PKC412 (midostaurin), a 60 year old male with normal karyotype AML was identified with FLT3-ITD-N676K mutation. This mutati… (full text at CIViC) PMID 16150941 · Heidel et al., 2006 · Open in CIViC | civic |
ClinVar
Clinical significance (0)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
Data not yet available